You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR MYDRIACYL

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for MYDRIACYL

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Stanford University	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	University of California, San Francisco	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Oregon Health and Science University	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT02373137 ↗	Descemet Endothelial Thickness Comparison Trial	Active, not recruiting	Winston Chamberlain, MD, PhD	Phase 4	2015-01-22	The purpose of this study is to compare visual acuity outcomes of two types of endothelial keratoplasty: 1) Ultrathin Descemet's Stripping Endothelial Keratoplasty (DSAEK) or 2) Descemet's Membrane Endothelial Keratoplasty (DMEK). Half of the participants will be randomized to have DSAEK and the other half will have DMEK.
NCT03959176 ↗	The Effect of Brimonidine	Completed	Wake Forest University Health Sciences	Phase 4	2019-07-20	This study will evaluate whether pre-treating patients with Brimonidine 0.2% before and/or after dilating the pupils will help to control the changes in intraocular pressure often seen when using dilating drops. The study will also evaluate the effects of different sequences of administering dilating drops along with Brimonidine on pupil size and reactivity.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for MYDRIACYL

Condition Name

Chart
Table

Condition Name for MYDRIACYL
Intervention	Trials
Grafting, Corneal	1
Intraocular Pressure	1
Keratoplasty	1
Keratoplasty, Lamellar	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for MYDRIACYL
Intervention	Trials
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for MYDRIACYL

Trials by Country

Map
Table

Trials by Country for MYDRIACYL
Location	Trials
United States	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for MYDRIACYL
Location	Trials
North Carolina	1
Oregon	1
California	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for MYDRIACYL

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for MYDRIACYL
Clinical Trial Phase	Trials
Phase 4	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for MYDRIACYL
Clinical Trial Phase	Trials
Active, not recruiting	1
Completed	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for MYDRIACYL

Sponsor Name

Chart
Table

Sponsor Name for MYDRIACYL
Sponsor	Trials
University of California, San Francisco	1
Oregon Health and Science University	1
Winston Chamberlain, MD, PhD	1
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for MYDRIACYL
Sponsor	Trials
Other	5
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.